Bacille Calmette–Guerin and Prospects for New Vaccines against Tuberculosis
- 6 February 2014
- book chapter
- Published by Taylor & Francis
- p. 339-350
- https://doi.org/10.1201/b16604-30
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-AnalysisPLoS Medicine, 2012
- IL-23 Is Required for Long-Term Control of Mycobacterium tuberculosis and B Cell Follicle Formation in the Infected LungThe Journal of Immunology, 2011
- A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adultsBMJ Open, 2011
- A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosisNature Medicine, 2011
- Viral Booster Vaccines Improve Mycobacterium bovis BCG-Induced Protection against Bovine TuberculosisInfection and Immunity, 2009
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeysProceedings of the National Academy of Sciences, 2009
- Live tuberculosis vaccines based onphoPmutants: a step towards clinical trialsExpert Opinion on Biological Therapy, 2008
- Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populationsEuropean Journal of Immunology, 2007
- Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6Vaccine, 2004
- A Reality in Our Time--Certification of the Global Eradication of SmallpoxThe Journal of Infectious Diseases, 1980